Related references
Note: Only part of the references are listed.Evidence-based pharmacotherapy of panic disorder: an update
Neeltje M. Batelaan et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2012)
Recent advances in Tourette syndrome
Michael Bloch et al.
CURRENT OPINION IN NEUROLOGY (2011)
Review of atypical antipsychotics in anxiety
Nienke C. C. Vulink et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2011)
Efficacy of Antipsychotic Augmentation Therapy in Treatment-Resistant Obsessive-Compulsive Disorder - A Meta-Analysis of Double-Blind, Randomised, Placebo-Controlled Trials
M. Dold et al.
FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE (2011)
The comparison of aripiprazole and risperidone augmentation in selective serotonin reuptake inhibitor-refractory obsessive-compulsive disorder: a single-blind, randomised study
Yavuz Selvi et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2011)
A critical review of pharmacotherapy for major depressive disorder
Jamie M. Dupuy et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2011)
Evidence-based pharmacological treatment of generalized anxiety disorder
David S. Baldwin et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2011)
Double-Blind, Placebo-Controlled Trial of Topiramate Augmentation in Treatment-Resistant Obsessive-Compulsive Disorder
Heather A. Berlin et al.
JOURNAL OF CLINICAL PSYCHIATRY (2011)
Effect of Aripiprazole Augmentation of Serotonin Reuptake Inhibitors or Clomipramine in Treatment-Resistant Obsessive-Compulsive Disorder A Double-Blind, Placebo-Controlled Study
Maria Rosaria A. Muscatello et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2011)
A Double-Blind, Randomized, Controlled Trial of Fluoxetine Plus Quetiapine or Clomipramine Versus Fluoxetine Plus Placebo for Obsessive-Compulsive Disorder
Juliana Belo Diniz et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2011)
Meta-analysis: Fact or fiction? How to interpret meta-analyses
Wolfgang Huf et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2011)
Switching from serotonin reuptake inhibitors to agomelatine in patients with refractory obsessive-compulsive disorder: a 3 month follow-up case series
Michele Fornaro
ANNALS OF GENERAL PSYCHIATRY (2011)
A double-blind, placebo-controlled pilot study of ondansetron for patients with obsessive-compulsive disorder
Farhad Soltani et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2010)
A Single-Blinded Case-Control Study of Memantine in Severe Obsessive-Compulsive Disorder
S. Evelyn Stewart et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2010)
Ondansetron Augmentation in Treatment-Resistant Obsessive-Compulsive Disorder A Preliminary, Single-Blind, Prospective Study
Stefano Pallanti et al.
CNS DRUGS (2009)
Quetiapine Augments the Effect of Citalopram in Non-Refractory Obsessive-Compulsive Disorder: A Randomized, Double-Blind, Placebo-Controlled Study of 76 Patients
Nienke C. C. Vulink et al.
JOURNAL OF CLINICAL PSYCHIATRY (2009)
A Long-Term Trial of the Effectiveness and Safety of Atypical Antipsychotic Agents in Augmenting SSRI-Refractory Obsessive-Compulsive Disorder
Hisato Matsunaga et al.
JOURNAL OF CLINICAL PSYCHIATRY (2009)
The Medical Treatment of Obssessive-Compulsive Disorder and Anxiety
Borwin Bandelow
CNS SPECTRUMS (2008)
Serotoninergic mechanisms in the treatment of obsessive-compulsive disorder
Andrew W. Goddard et al.
DRUG DISCOVERY TODAY (2008)
8-week, single-blind, randomized trial comparing risperidone versus olanzapine augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder
Giuseppe Maina et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2008)
Riluzole augmentation in treatment-refractory obsessive-compulsive disorder - A series of 13 cases, with long-term follow-up
Christopher Pittenger et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2008)
Quetiapine addition to serotonin reuptake inhibitors in patients with severe obsessive-compulsive disorder: A double-blind, randomized, placebo-controlled study
Andreas Kordon et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2008)
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Post-Traumatic Stress Disorders - First Revision
Borwin Bandelow et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2008)
Escitalopram prevents relapse of obsessive-compulsive disorder
Naomi A. Fineberg et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2007)
Escitalopram in obsessive-compulsive disorder: a randomized, placebo-controlled, paroxetine-referenced, fixed-dose, 24-week study
Dan J. Stein et al.
CURRENT MEDICAL RESEARCH AND OPINION (2007)
Quetiapine addition in obsessive-compulsive disorder: Is treatment outcome affected by type and dose of serotonin reuptake inhibitors?
Damiaan Denys et al.
BIOLOGICAL PSYCHIATRY (2007)
Antipsychotic augmentation of serotonergic antidepressants in treatment-resistant obsessive-compulsive disorder: A meta-analysis of the randomized controlled trials
Petros Skapinakis et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2007)
A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder
M. H. Bloch et al.
MOLECULAR PSYCHIATRY (2006)
Treatment-refractory obsessive-compulsive disorder: Methodological issues, operational definitions and therapeutic lines
S Pallanti et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2006)
High-dose sertraline strategy for nonresponders to acute treatment for obsessive-compulsive disorder: A multicenter double-blind tyial
PT Ninan et al.
JOURNAL OF CLINICAL PSYCHIATRY (2006)
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 2: Long-term treatment of schizophrenia
P Falkai et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2006)
Riluzole augmentation in treatment-resistant obsessive-compulsive disorder: An open-label trial
V Coric et al.
BIOLOGICAL PSYCHIATRY (2005)
Adding quetiapine to SRI in treatment-resistant obsessive-compulsive disorder: a randomized controlled treatment study
NA Fineberg et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2005)
Risperidone and haloperidol augmentation of serotonin reuptake inhibitors in refractory obsessive-compulsive disorder: A crossover study
XH Li et al.
JOURNAL OF CLINICAL PSYCHIATRY (2005)
Quetiapine augmentation of SRIs in treatment refractory obsessive-compulsive disorder: a double-blind, randomised, placebo-controlled study [ISRCTN83050762]
Paul D. Carey et al.
BMC PSYCHIATRY (2005)
Low-dose risperidone augmentation of fluvoxamine treatment in obsessive-compulsive disorder: a double-blind, placebo-controlled study
S Erzegovesi et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2005)
A double-blind, placebo-controlled trial of olanzapine addition in fluoxetine-refractory obsessive-compulsive disorder
NA Shapira et al.
BIOLOGICAL PSYCHIATRY (2004)
A multidimensional meta-analysis of psychotherapy and pharmacotherapy for obsessive-compulsive disorder
KT Eddy et al.
CLINICAL PSYCHOLOGY REVIEW (2004)
Risperidone augmentation in treatment-resistant obsessive-compulsive disorder: a double-blind, placebo-controlled study
E Hollander et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2003)
Amisulpiride augmentation in treatment resistant obsessive-compulsive disorder:: an open trial
Ö Metin et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2003)
Citalopram intravenous infusion in resistant obsessive-compulsive disorder: An open trial
S Pallanti et al.
JOURNAL OF CLINICAL PSYCHIATRY (2002)
A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder
CJ McDougle et al.
ARCHIVES OF GENERAL PSYCHIATRY (2000)
Share Paper
